PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PDAC - PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: new combo aims to extend lives in pancreatic cancer
Disease control Not yet recruitingThis study tests whether adding focused radiation (SBRT) and an immunotherapy drug (serplulimab) to standard chemotherapy can help people with advanced pancreatic cancer live longer. About 198 adults who have not had prior treatment for their metastatic disease will be randomly a…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 17, 2026 07:10 UTC
-
Personalized cancer testing: a new way to match drugs to tumors?
Knowledge-focused Not yet recruitingThis study is testing a new method called Personalized Functional Profiling (PFP) to see if it can predict which standard cancer drugs will work best for people with colorectal or pancreatic cancer. Researchers will take tumor samples from 188 patients, grow them in the lab, and …
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC